Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Equity Ratio (2024 - 2025)

Historic Equity Ratio for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to 0.65.

  • Pyxis Oncology's Equity Ratio fell 1722.77% to 0.65 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.65, marking a year-over-year decrease of 1722.77%. This contributed to the annual value of 0.77 for FY2024, which is N/A changed from last year.
  • Per Pyxis Oncology's latest filing, its Equity Ratio stood at 0.65 for Q3 2025, which was down 1722.77% from 0.71 recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Equity Ratio peaked at 0.84 during Q1 2024, and registered a low of 0.65 during Q3 2025.